About PTS Diagnostics
PTS Diagnostics is a company based in Indianapolis (United States) founded in 1992 was acquired by Sinocare in May 2016. The company has 211 employees as of December 31, 2021. PTS Diagnostics offers products and services including A1CNow System, CardioChek Analyzers, and PTS Panels Test Strips. PTS Diagnostics operates in a competitive market with competitors including SD Biosensor, 1Drop Diagnostics, DiabetOmics, DxGen and Nova Biomedical, among others.
- Headquarter Indianapolis, United States
- Employees 211 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PTS Diagnostics
PTS Diagnostics offers a comprehensive portfolio of products and services, including A1CNow System, CardioChek Analyzers, and PTS Panels Test Strips.
Provides fast A1C results via fingerstick for diabetes monitoring.
Offers quick lipid panel testing for heart disease assessment.
Enables flexible testing with analyzers for various health metrics.
People of PTS Diagnostics
Unlock access to complete
Funding Insights of PTS Diagnostics
Detailed funding history for PTS Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in PTS Diagnostics
PTS Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sinocare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Point-of-care devices for chronic diseases are developed and marketed.
|
Locked | Locked | Locked |
Investor details for PTS Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PTS Diagnostics
Investment portfolio details for PTS Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PTS Diagnostics
Detailed financials for PTS Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pts Diagnostics Comparisons
Peer comparison for PTS Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PTS Diagnostics
PTS Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, 1Drop Diagnostics, DiabetOmics, DxGen and Nova Biomedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
Finger-prick point-of-care diagnostics are provided for biomarker testing.
|
|
| Locked | Locked | Locked |
Point-of-care tests for diabetes and women's health risks are developed.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic products for diabetes and tuberculosis are provided.
|
|
| Locked | Locked | Locked |
Developer of advanced blood testing analyzers and meters. This company manufactures and sells a wide variety of analyzers for hospital, point-of-care, blood bank, biotechnology, veterinary, and sports medicine applications. Products include blood gas analyzers, glucose meters, lactate meters, and cell culture analyzers. They also offer contract development and manufacturing services for other medical device companies. The analyzers utilize various measurement technologies, including potentiometric, amperometric, and spectrophotometric methods. The company provides complete technical support and product information globally.
|
Detailed competitors of PTS Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pts Diagnostics
Complete news archive for PTS Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PTS Diagnostics
PTS Diagnostics was founded in 1992.
PTS Diagnostics is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
As of Dec 31, 2021, the latest employee count at PTS Diagnostics is 211.
PTS Diagnostics was founded in 1992 and is headquartered in Indianapolis, United States. Operations focus on the medical diagnostics sector, where point-of-care blood collection devices, testing instruments, and information management systems are produced. These tools are applied in monitoring conditions such as heart disease and diabetes. Key products include the A1CNow system for diabetes management and the CardioChek analyzer for cardiac risk assessment.
PTS Diagnostics's top competitors include SD Biosensor, Nova Biomedical and 1Drop Diagnostics.
PTS Diagnostics offers A1CNow System, CardioChek Analyzers, and PTS Panels Test Strips.
PTS Diagnostics has 1 investor. Key investors include Sinocare.